Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
Objectives: To systematically review and assess the quality of the economic evidence of adjuvant trastuzumab usage in early breast cancer in Asian countries. Methods: Literature search was performed using 6 electronic databases (PubMed, Scopus, Ovid MEDLINE, EconLit, National Health Service Economic...
Main Authors: | Abdul Rafar, Noor Razilah, Hong, Yet Hoi, Wu, David Bin-Chia, Othman, Muhamad Faiz, Neoh, Chin Fen |
---|---|
Format: | Article |
Published: |
Elsevier
2019
|
Subjects: |
Similar Items
-
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer
by: Iwata, Hiroji, et al.
Published: (2019) -
Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah … [et al.]
by: Hasbullah, Harissa H, et al.
Published: (2018) -
Depression, anxiety and streee in young adult breast cancer women undergoing adjuvant therapy in HUSM
by: Leng, Leong Yee
Published: (2011) -
Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
by: Eraso, Yolanda
Published: (2019) -
The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
by: Hassan, Nor Hasnina Mohd
Published: (2016)